Arcus Biosciences 株価情報 (NYSE: RCUS)

Arcus Biosciences (NYSE:RCUS) 株価情報

Arcus Biosciences

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Analyst Ratings

RCUS

アルカス・バイオサイエンス（Arcus Biosciences）（NYSE:RCUS）の株価予測がまたしても分析され、多くのアナリストの間でさまざまな意見が出された。

アルカス・バイオサイエンス　株価予測を公表

Arcus Biosciences Inc

<ul>
<li>New agreement spans packet core, signaling, charging &amp; policy solutions</li>
</ul>

News

ERIC

Bharti Airtel Partners With Ericsson To Deploy Advanced 5G Core Technology For India's 5G Evolution

51Talk Integrates AI Across Its Platform, Enhancing Personalized Learning And Operational Efficiency

JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) CEO Jamie Dimon has voiced criticism over the efficiency of the U.S. government and shown support for the Department of Government Efficiency (DOGE) overseen by Elon Musk.
What Happened: In an interview with <a href="https://www.cnbc.com/2025/02/24/jamie-dimon-us-government-inefficient-touts-elon-musk-doge-effort.html">CNBC</a>&#8216;s Leslie Picker on Monday, Dimon labeled the government as &#8220;inefficient&#8221; and &#8220;not very competent,&#8221; implying that it &#8220;needs a lot of work.&#8221; Although he didn&#8217;t provide a clear-cut response about his stance on DOGE&#8217;s initiatives, his remarks suggested a general endorsement.
Dimon also mentioned the Trump administration&#8217;s initiatives to cut spending and closely examine federal agencies, stating such actions &#8220;need to be done.&#8221; He underscored the need for building appropriate policies and procedures and questioned the benefits derived from government spending.
While Dimon expressed support for DOGE&#8217;s cost-cutting initiatives, he also cautioned against any potential overreach or illegal activities, stating that &#8220;the courts will stop it.&#8221; Nevertheless, Dimon added, "I'm hoping it's quite successful.&#8221;
SEE ALSO: <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43930754/bitcoin-ethereum-dogecoin-bleed-amid-trumps-tariff-threat-bybit-mega-breach-analyst-says-mid-bull-reset-not-unprecedented-full-blown-bear-market-not-yet-here">Bitcoin, Ethereum, Dogecoin Bleed Amid Trump&#8217;s Tariff Threat, Bybit Mega Breach: Analyst Says &#8216;Mid-Bull Reset&#8217; Not Unprecedented, Full-Blown Bear Market Not Yet Here</a>
Why It Matters: Dimon&#8217;s comments come in the backdrop of his recent reconciliation with Elon Musk, CEO of Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>). In late January, Dimon referred to <a href="https://www.benzinga.com/startups/25/01/43339032/jamie-dimon-calls-elon-musk-our-einstein-after-years-of-feuds-weve-hugged-it-out-and-settled-differences-at-tech-summit">Musk as &#8216;Our Einstein&#8217;</a> after years of public feuds and legal disputes. The two reportedly &#8220;hugged it out&#8221; and settled their differences at a tech summit.
The JPMorgan CEO has also expressed his support for President Donald Trump&#8216;s tariff policy, previously. In January, he had told CNBC, that the upcoming tariffs by the Trump administration could be seen in a positive light. "If it's a little inflationary but it's good for national security, so be it. I mean, get over it," Dimon had said. 
Jamie Dimon recently courted controversy after he <a href="https://www.benzinga.com/markets/equities/25/02/43757032/jamie-dimon-goes-off-on-return-to-office-critics-you-dont-have-to-work-at-jpmorgan">condemned remote work</a>, arguing that it hinders creativity and negatively impacts the social and professional development of younger employees. 
Notably, while the JPMorgan CEO has voiced his support for Musk&#8217;s DOGE initiative, several others have criticized the transparency and working of DOGE. A <a href="https://www.benzinga.com/markets/25/02/43906977/elon-musks-doge-savings-of-55-billion-may-be-overstated-wsj-analysis-reveals-the-likely-actual-figure">recent analysis by WSJ</a> also revealed that the savings mentioned on the DOGE website could be overstated. 
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/personal-finance/25/02/43929806/dave-ramsey-says-its-very-difficult-to-trust-someone-in-pajamas-on-a-zoom-call-admits-hes-the-crotchety-old-boss">Dave Ramsey Says &#8216;It&#8217;s Very Difficult To Trust Someone In Pajamas On A Zoom Call&#8217;—Admits He&#8217;s &#8216;The Crotchety Old Boss&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Markets

Tech

TSLA

Jamie Dimon Slams 'Inefficient' US Government, Backs Elon Musk's DOGE Initiative

EpoVIVE&#x2122;, an epoxy product portfolio offering a range of sustainable characteristics across multiple products, which will support customer sustainability initiatives. The EpoVIVE&#x2122; portfolio of Epoxy phenolic, resins and curing agents, represents a significant step forward in the commitment to drive sustainable innovation and foster value-chain collaboration. EpoVIVE&#x2122; products are developed with an environmentally conscious mindset.

Westlake Epoxy Introduces EpoVIVE At JEC World 2025, Advancing Sustainable Epoxy Solutions

<ul>
<li>Contentserv provides the all-in-one cloud-based platform for PIM, DAM, Content Syndication and Digital Shelf Analytics (DSA)</li>
<li>Platform enables FMCG companies to craft and optimize product content to reduce time to market, increase product sell-through and curate personalized consumer experiences</li>
</ul>

DASTY

Dassault Systemes' Centric Software Acquires AI-Powered PXM Leader Contentserv For €220M

Macro Economic Events

Econ #s

Economics

Germany Gross Domestic Product (YoY) For Q4 -0.2% Vs. -0.2% Est.; -0.3% Prior

Germany Gross Domestic Product (QoQ) For Q4 -0.2% Vs. -0.2% Est.; 0.1% Prior

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma&nbsp;
<ul>
<li>Approval offers access to new treatment options for newly diagnosed MM patients</li>
<li>Approval based on positive results from the IMROZ phase 3 study that demonstrated Sarclisa in combination with VRd significantly improved progression-free survival, compared to VRd alone in transplant-ineligible newly diagnosed multiple myeloma</li>
</ul>

Sanofi Gains Japanese Approval For Sarclisa In Newly Diagnosed Multiple Myeloma Patients

Billionaire entrepreneur and Dallas Mavericks owner Mark Cuban has called the U.S. healthcare system, &#8220;f&#x2A;&#x2A;&#x2A;&#x2A;d up&#8221; while highlighting deductibles as &#8220;the biggest problem in healthcare,&#8221; which are designed by insurance companies.
What Happened: Cuban explained in his latest X post that insurance companies design plans with higher deductibles and lower premiums leaving the work of bill collection in the hands of doctors and hospitals.
A deductible is the amount of money paid by the patient before their insurance company pays for the covered expenses as chosen under their policy.
&#8220;Often we choose higher deductibles because we are healthy or because we can only afford the lowest premium plan,&#8221; adds Cuban, inferring that if higher deductibles were left unpaid hospitals end up becoming &#8220;bill collectors,&#8221; &#8220;DESPITE HAVING NO SAY in the (insurance) plans&#8221; and deductibles bracket that patients choose.
"That is one fucked up system that needs to be redesigned," adds Cuban.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Want to know one of the biggest problems in healthcare? Deductibles. Deductibles are defined by the plans the insurance companies design. Then they are approved to be offered by the feds or employers. Then we the people decide what deductible we want when we choose our plans.…
&mdash; Mark Cuban (@mcuban) <a href="https://twitter.com/mcuban/status/1894236347847618571?ref_src=twsrc%5Etfw">February 25, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/government/regulations/25/02/43912631/apple-forced-to-kiss-the-ring-expert-questions-whether-trump-pushed-the-iphone-maker-for-500-billion-investment">Apple &#8216;Forced To Kiss The Ring&#8217;? Expert Questions Whether Trump Pushed The iPhone Maker For $500 Billion Investment</a>
Why It Matters: Cuban&#8217;s tweets shed light on the growing problem of high deductibles in the U.S. healthcare system.
The "higher deductibles" turn out to be out-of-pocket costs which create a barrier to accessing care, potentially leading to delayed treatment, worsening health conditions, and mounting medical debt.
Cuban concluded his post by calling out insurance company practices that contribute to healthcare costs, including &#8220;delay tactics&#8221; and denials of claims. He called for a redesigned system for patient well-being and fairness for healthcare providers.
Here is a list of Insurance sector ETFs that investors could look at:
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>ETFs</td>
<td>YTD Performance</td>
<td>One Year Performance</td>
</tr>
<tr>
<td>SPDR S&amp;P Insurance ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIE#NYSE">KIE</a>)</td>
<td>3.30%</td>
<td>17.59%</td>
</tr>
<tr>
<td>iShares US Insurance ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAK#NYSE">IAK</a>)</td>
<td>3.66%</td>
<td>17.32%</td>
</tr>
<tr>
<td>Invesco KBW Property &amp; Casualty Insurance ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBWP#NASDAQ">KBWP</a>)</td>
<td>-0.33%</td>
<td>12.48%</td>
</tr>
</tbody>
</table>
</figure>
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell on Monday. SPY declined 0.46% to $597.21, and QQQ plunged 1.18% to $519.87, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43906366/warren-buffetts-berkshire-boosts-bets-on-five-japanese-companies-admiration-has-consistently-grown-says-oracle-of-omaha-in-letter-to-shareholders">Warren Buffett&#8217;s Berkshire Boosts Bets On 5 Japanese Companies: Oracle Of Omaha Says Admiration &#8216;Has Consistently Grown&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Sector ETFs

Insurance

ETFs

iShares Dow Jones US Insurance Index Fund

KBWP

Mark Cuban Calls Deductibles 'The Biggest Problem' in Healthcare: 'System…Needs To Be Redesigned'

Will significantly shorten digital transformation development period

MIELY

Reported Earlier, Mitsubishi Electric Develops First-Ever System To Digitize Operator Expertise For Smarter Operations

TRGP

Reported Earlier, Targa Resources Prices $2B In Senior Notes: $1B 5.550% Due 2035 And $1B 6.125% Due 2055

Reported Earlier, Accenture Unveils AI Solutions To Help Businesses Leverage Google Cloud And Salesforce Technology

OXBR

Reported Earlier, Oxbridge Announces $3M Capital Raise Through Registered Offering And Private Placement

Unity also granted the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $90.0 million aggregate principal amount of Notes. The sale of the Notes to the initial purchasers is expected to close on February 27, 2025, subject to customary closing conditions.
The Notes will be general unsecured obligations of Unity and will not bear regular interest, and the principal amount of the Notes will not accrete. The Notes will mature on March 15, 2030, unless earlier converted, redeemed or repurchased.

Reported Earlier, Unity Prices Upsized $600M 0% Convertible Senior Notes Due 2030

Reported Earlier, EHang Forms Strategic Partnership With JAC Motors And Guoxian Holdings To Develop eVTOL Manufacturing Hub

Grupo Aeroportuario del (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAC#NYSE">PAC</a>) reported quarterly earnings of Ps. 4.50 per share which beat the analyst consensus estimate of Ps. 4.35 by 3.47 percent. This is a 16.23 percent increase over earnings of Ps .3.87 per share from the same period last year. The company reported quarterly sales of Ps .9.63 billion which beat the analyst consensus estimate of Ps. 9.02 billion by 6.67 percent. This is a 5.43 percent increase over sales of Ps. 9.13 billion the same period last year.

Earnings

Earnings Beats

Grupo Aeroportuario del Q4 2024 GAAP EPS Ps. 4.50 Beats Ps .4.35 Estimate, Sales Ps .9.63B Beat Ps. 9.02B Estimate

EV giant Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has begun rolling out new driving assistance features for its vehicles on city streets in China, as promised last year.
What Happened: The features are being rolled out via a software update and are similar to those included under the company&#8217;s full self-driving software in the U.S., according to an app notification from the company shared by enthusiasts on social media.
Following the update, the vehicle will identify traffic lights, allow for automatic lane changes, and more, the notification said. The cabin camera will also monitor whether the driver is paying attention to the road while the features are working.
The company is pushing out the update to vehicles in batches on some models, the company said, while adding that the range of compatible models will be gradually expanded.
The new features are limited to customers who paid for FSD. In China, it is priced at 64,000 yuan above the purchase price of the vehicle. It is unclear how many vehicle owners have paid for the service. 
Why It Matters: In September, Tesla said that it would roll out FSD&nbsp;in Europe and China in the <a href="https://www.benzinga.com/news/24/09/40724069/tesla-fsd-rollout-in-china-europe-planned-for-q1-2025">first quarter of 2025</a>, pending regulatory approval.
In January, during the company&#8217;s fourth-quarter earnings call, company CEO Elon Musk said that the company is faced with &#8220;challenges&#8221; in rolling out the software in China. While China doesn't allow training videos from Tesla vehicles in the country to be transferred back to the U.S., the U.S. government doesn't allow the company to train the software in China, <a href="https://www.benzinga.com/tech/25/02/43647669/tesla-releases-supervised-full-self-driving-in-mexico-says-hola-to-local-drivers">Musk said</a>, terming it "a bit of a quandary." Tesla has been using videos of roads in China on the internet to train the software, he added. 
FSD is the advanced version of the company's autopilot driver assistance technology. The name is a misnomer and doesn't allow for completely autonomous driving as of today.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43909679/tesla-cybercab-will-have-no-stainless-steel-panels-and-will-not-be-painted-either-says-senior-company-exec">Tesla&#8217;s Cybercab To Ditch Stainless Steel And Paint, Says Senior Company Exec: Here&#8217;s How It Will Get Its Signature Gold Look</a></li>
</ul>
Photo courtesy: Shutterstock

Tesla Starts Rolling Out FSD Features In China A Month After Elon Musk Said EV Giant Faces 'Challenges' In The Country

Woodside Energy Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDS#NYSE">WDS</a>) reported quarterly earnings of $1.87 per share. This is a 115.07 percent increase over earnings of $0.87 per share from the same period last year. The company reported $13.18 billion in sales this quarter. This is a 5.82 percent decrease over sales of $13.99 billion the same period last year.

Woodside Energy Group FY 2024 GAAP EPS $1.87 Up From $0.87 YoY, Sales $13.18B Down From $13.99B YoY

2025 Annual Guidance
(in thousands, except percentages, per share amounts, and ratios)
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="5">Full Year 2025 Guidance</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Low</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>High</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Net income&nbsp;(1) (2)</td>
<td>$</td>
<td>253,000</td>
<td>$</td>
<td>293,000</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Adjusted EBITDA(3)</td>
<td>750,000</td>
<td>790,000</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Cash available for dividend(4) (5)</td>
<td>456,000</td>
<td>471,000</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Segment</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Contract operations revenue</td>
<td>$</td>
<td>1,200,000</td>
<td>$</td>
<td>1,235,000</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Contract operations adjusted gross margin percentage</td>
<td>68</td>
<td>%</td>
<td>71</td>
<td>%</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Aftermarket services revenue</td>
<td>$</td>
<td>190,000</td>
<td>$</td>
<td>210,000</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Aftermarket services adjusted gross margin percentage</td>
<td>22</td>
<td>%</td>
<td>24</td>
<td>%</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Selling, general and administrative</td>
<td>$</td>
<td>147,000</td>
<td>$</td>
<td>142,000</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Capital expenditures</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Growth capital expenditures</td>
<td>$</td>
<td>330,000</td>
<td>$</td>
<td>370,000</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Maintenance capital expenditures</td>
<td>105,000</td>
<td>115,000</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Other capital expenditures</td>
<td>35,000</td>
<td>50,000</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
</figure>

Guidance

AROC

Archrock 2025 Guidance: Expects Net Income Of $253M-$293M, And Adj. EBITDA Of $750M-$790M

Archrock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AROC#NYSE">AROC</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.30 by 16.67 percent. This is a 66.67 percent increase over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $326.42 million which missed the analyst consensus estimate of $330.63 million by 1.27 percent. This is a 25.74 percent increase over sales of $259.59 million the same period last year.

Earnings Misses

Archrock Q4 2024 Adj EPS $0.35 Beats $0.30 Estimate, Sales $326.42M Miss $330.63M Estimate

Press Releases

Arcus Biosciences to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer

Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium

New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer

Arcus Biosciences, Inc. Announces Underwritten Offering of Common Stock

Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering

Comments

Arcus Biosciences

ニュース

パートナーシップ

ベンジンガ・グローバル